Related Experiment Video
Updated: Sep 26, 2025

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
A procedurally activatable nanoplatform for chemo/chemodynamic synergistic therapy
Wen Han1, Min Wang1, Huaming He1
1Key Laboratory for Analytical Science of Food Safety and Biology of the MOE, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350116, P. R. China. chunhualu@fzu.edu.cn.
Abstract:
Responsive nano-drug delivery systems, especially multi-responsive systems, based on the complex characteristics of the tumor microenvironment (TME), such as acidic pH, hypoxia, and hydrogen peroxide (H2O2) overexpression, could enhance the biological activity of the drugs and reduce the side effects. In this study, a H2O2/glutathione (GSH) procedurally activatable nanoplatform (Cu9S5-PEG/DOX NSs) was prepared as a vector of drugs released by responsive morphologic transformation and the co-activated Fenton agent for tumor-specific synergistic therapy. After endocytosis into tumor cells, Cu9S5-PEG/DOX NSs were initially oxidized by over-expressed H2O2 and transformed from nanosheets to nanoflowers, leading to the release of doxorubicin (DOX). Subsequently, Cu9S5 nanoflowers (Cu9S5 NFs) reacted with the local GSH, liberated a large number of copper ions, and induced GSH depletion. The released DOX promoted the generation of intracellular H2O2 through cascade reactions, which were further utilized to facilitate the release of DOX and generate toxic hydroxyl radicals (˙OH) via a copper-based Fenton-like reaction. Cu9S5-PEG/DOX NSs sequentially activated by H2O2 and GSH in tumor cells exhibited relatively high cytotoxicity, whereas normal cells were still alive. This nanoplatform, as a procedurally activatable delivery system, may have excellent potential for tumor-specific synergistic therapy.
More Related Videos
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...